Loading
Life sciences · Journal article
Current Opinion in Endocrinology Diabetes and Obesity · September 18, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Purpose of review Recent guidelines emphasize the significance of measuring adiposity rather than relying solely on BMI. This shift underscores the importance of normal-weight obesity (NWO), which is identified by assessing body fat percentage. This review presents recent advances in understanding NWO, including several substantial cohort studies that examine its prevalence, pathophysiology, and clinical implications. Recent findings The prevalence of NWO is notably high. Extensive cohort studies have established its association with increased cardiometabolic mortality, changes in microbiota diversity and composition, and alterations in body composition, including a reduction in brown adipose tissue. Body composition metrics, such as the android–gynoid ratio, have emerged as significant indicators of metabolic health. Additionally, the association with ultra-processed foods underscores the need to integrate nutrition and exercise regimens into treatment protocols. Summary NWO represents a clinically significant condition that requires early diagnosis to improve cardiometabolic outcomes.